Valuation: Evogene Ltd.

Market Cap 6M 1.85B 5.34M 4.95M 4.49M 8.44M 569M 8.56M 59.28M 23.3M 298M 22.5M 22.04M 950M P/E 2026 *
-
P/E 2027 * -
Enterprise Value 6M 1.85B 5.34M 4.95M 4.49M 8.44M 569M 8.56M 59.28M 23.3M 298M 22.5M 22.04M 950M EV / Sales 2026 *
4.18x
EV / Sales 2027 * 2.31x
Free-Float
75.61%
Yield 2026 *
-
Yield 2027 * -
1 day-1.84%
1 week-2.09%
Current month-8.35%
1 month-23.77%
3 months-31.94%
6 months-52.00%
Current year-60.94%
1 week 116.1
Extreme 116.1
127
1 month 113.3
Extreme 113.3
164.6
Current year 113.3
Extreme 113.3
410
1 year 113.3
Extreme 113.3
439.8
3 years 113.3
Extreme 113.3
3,700
5 years 113.3
Extreme 113.3
9,250
10 years 113.3
Extreme 113.3
33,500
Manager TitleAgeSince
Chief Executive Officer 60 30/11/2004
Corporate Officer/Principal - -
Corporate Officer/Principal - 31/12/2021
Director TitleAgeSince
Director/Board Member 60 -
Director/Board Member 77 02/06/2010
Chairman 60 31/05/2021
Date Insider Type Main position Quantity % Market Cap. Importance
04/09/26 Free

Chairman

10,000 0.0754%
04/09/26 Other

Director

2,500 0.0189%
04/09/26 Free

Director

2,500 0.0189%
Change 5-day change 1-year change 3-year change Capi.($)
-1.84%-2.09%-71.91%-94.12% 6.09M
+0.79%-6.46%+52.86%+71.34% 65.83B
+1.92%+8.89%+12.90%+82.75% 51.87B
+6.91%+6.41%+9.61%+73.07% 51.2B
+0.74%+2.15%+30.95%+43.43% 43.76B
+3.87%+9.73%+21.52%+142.33% 42.09B
+7.91%+1.34%+263.31%+577.76% 39.04B
-0.40%+9.42%+18.44%+59.06% 34B
+3.84%-4.94%+42.35%+8.92% 25.2B
+2.36%+4.62%+24.20%+31.02% 22.8B
Average +2.61%+0.44%+40.42%+99.55% 37.58B
Weighted average by Cap. +3.05%+0.62%+51.69%+122.71%

Financials

2026 *2027 *
Net sales 1.44M 443M 1.28M 1.19M 1.07M 2.02M 136M 2.05M 14.19M 5.58M 71.21M 5.39M 5.27M 227M 2.6M 803M 2.32M 2.15M 1.94M 3.66M 246M 3.71M 25.69M 10.1M 129M 9.75M 9.55M 412M
Net income -12.17M -3.76B -10.84M -10.05M -9.1M -17.12M -1.15B -17.36M -120M -47.25M -603M -45.64M -44.7M -1.93B -10.2M -3.15B -9.08M -8.42M -7.63M -14.35M -967M -14.55M -101M -39.61M -506M -38.26M -37.46M -1.61B
Net Debt - -
Projected Income Statement - Annual - Evogene Ltd.
Logo Evogene Ltd.
Evogene Ltd is an Israel-based company, engaged in leveraging computational biology to design products for life-science-based industries including human health, agriculture, and industrial applications. Leveraging Big Data and Artificial Intelligence while incorporating a deep understanding of biology, Evogene established its technology, the Computational Predictive Biology (CPB) platform, to computationally design microbes, small molecules and genes as the core components for life-science products. Evogene holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production.
Employees
52
Date Price Change Volume
20/10/26 ILA 117.40 -1.84% 66,273
19/10/26 ILA 119.60 +0.25% 102,759
16/10/26 ILA 119.30 -1.40% 78,333
15/10/26 ILA 121.00 -0.41% 19,717
14/10/26 ILA 121.50 -2.96% 39,709

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Evogene Ltd.
  1. Stock Market
  2. Stocks
  3. EVGN Stock